Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -169,866 | -80,481 | -224,187 | -155,614 | -89,444 |
| Depreciation Amortization | 7,204 | 2,972 | 13,533 | 10,938 | 7,052 |
| Income taxes - deferred | N/A | N/A | -2,938 | -2,731 | -1,029 |
| Accounts payable and accrued liabilities | 2,600 | 6,497 | 2,570 | 7,275 | 2,287 |
| Other Working Capital | -398 | 5,486 | 16,360 | 13,279 | 419 |
| Other Operating Activity | 30,396 | 5,057 | 22,938 | 12,733 | 3,586 |
| Operating Cash Flow | $-130,064 | $-60,469 | $-171,724 | $-114,120 | $-77,129 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,303 | 7,003 | -83,493 | -31,571 | -13,328 |
| PPE Investments | -15,128 | -7,083 | -1,669 | -2,368 | -324 |
| Sale Of Investment | 44,159 | 31,925 | 65,350 | 6,582 | 42,920 |
| Investing Cash Flow | $42,334 | $31,845 | $-19,812 | $-27,357 | $29,268 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 40,000 | 40,000 | 150,002 | 63,700 | N/A |
| Common Stock Issued | 99,458 | 1,121 | 1,176 | 87,219 | 87,380 |
| Other Financing Activity | -2,624 | -2,624 | -503 | -485 | -163 |
| Financing Cash Flow | $136,834 | $38,497 | $150,675 | $150,434 | $87,217 |
| Exchange Rate Effect | -61 | -109 | -25 | -73 | 5 |
| Beginning Cash Position | 35,094 | 35,094 | 75,980 | 75,980 | 75,980 |
| End Cash Position | 84,137 | 44,858 | 35,094 | 84,864 | 115,341 |
| Net Cash Flow | $49,043 | $9,764 | $-40,886 | $8,884 | $39,361 |
| Free Cash Flow | |||||
| Operating Cash Flow | -130,064 | -60,469 | -171,724 | -114,120 | -77,129 |
| Capital Expenditure | -15,128 | -7,083 | -1,669 | -2,368 | -324 |
| Free Cash Flow | -145,192 | -67,552 | -173,393 | -116,488 | -77,453 |